FDA Issues Voluntary Recall of Blood Pressure Medication Due to Cancer Concerns

A voluntary recall of a blood pressure medication due to impurities, which may lead to a cancer risk, was recently issued by Sandoz Inc. The company …

New Exercise Guidelines Encourage Americans to Get Up And Move

Americans looking to be more healthy can exercise in smaller segments in shorter bursts of time, according to new guidelines released by the …

New Ways to Heal Diabetic Foot Ulcers Quickly

The Centers for Disease Control reports that 15 percent of Americans living with type 2 diabetes struggle with hard-to-heal foot ulcers. Now, a …

Diabetes Drug Prevents Heart Failure; Kidney Risks

In the largest trial of its kind to determine the cardiovascular outcomes for a new class of diabetes medications, Astra Zeneca’s Farxiga was …

ADA And AHA Partner-up for New Initiative, “Know Diabetes by Heart”

The American Diabetes Association (ADA) and the American Heart Association (AHA) announced a new partnership to raise awareness about the increased …

FDA Approves Mobile App for Abbott’s Freestyle Libre

A new mobile app for Abbott’s Freestyle Libre 10-day and 14-day glucose monitoring systems has been approved for use in the U.S. by the FDA. It …

FDA Approves Expansion of Eversense® CGM Certification to NPs and PAs

Senseonics Holdings, Inc. announced that the FDA has approved the insertion and removal of its Eversense® Continuous Glucose Monitoring (CGM) …

Study: Marijuana Users at Higher Risk for Serious Type 1 Diabetes Complications

Individuals with type 1 diabetes may be at increased risk for serious complications when they used marijuana, new research suggests. Marijuana use is …

Lilly’s Trulicity® Shows Reduction of Cardiovascular Events for Broad Range of People with Type 2 Diabetes

Eli Lilly and Company reported that it’s drug, Trulicity® significantly reduced major adverse cardiovascular events, a composite endpoint of …

Endocrine Society Urges More Transparency to Combat Soaring Insulin Costs

Out-of-control insulin costs have created a dangerous barrier for many people with diabetes who need to access lifesaving treatments. According to …